Nokia of America Corporation BBTRX-14 사용자 설명서
FDA/IEC optical transmitter product compliance statements
FDA/IEC optical transmitter product compliance
Alcatel-Lucent declares that this equipment complies with the Food and Drug
Administration’s Center for Devices and Radiological Health (FDA/CDRH) regulations
21 CFR 1040.10 and 1040.11. It is a Class I/1 laser optical fiber communication systems
“product” under the FDA.
Administration’s Center for Devices and Radiological Health (FDA/CDRH) regulations
21 CFR 1040.10 and 1040.11. It is a Class I/1 laser optical fiber communication systems
“product” under the FDA.
This Product is designed to ensure that personnel operating the product are not
endangered by laser radiation during normal operation and fault conditions. This product
does not present a risk of eye injury because it is fully enclosed and does not contain
embedded lasers greater than Class I/1 unless otherwise noted.
endangered by laser radiation during normal operation and fault conditions. This product
does not present a risk of eye injury because it is fully enclosed and does not contain
embedded lasers greater than Class I/1 unless otherwise noted.
Product conformance statements
United States compliance
United States compliance
FDA/IEC optical transmitter product compliance statements
....................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................
B-6
Alcatel-Lucent – Proprietary
Use pursuant to applicable agreements
Alcatel-Lucent 9763 MCI
3MN-MCI-IMOP
Issue 1
December 2013